LEARNING OBJECTIVES

1.    Understand relevant clinical/pathologic features associated with high grade serous ovarian carcinoma (HGSOC) including disease stage, histology, and associated lab abnormalities
2.    Incorporate clinical trial results into clinical decision making for HGSOC in the frontline setting
3.    Briefly discuss emerging therapeutic trials – Zn-C3
 

Session date: 
01/30/2025 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Hannah Johnston, MD